• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Consumers hit social media with concerns over J&J’s talc powder

Consumers hit social media with concerns over J&J’s talc powder

February 24, 2016 By Brad Perriello

Johnson & Johnson(Reuters) — Consumers expressed concern on social media about a talc-based baby powder made by Johnson & Johnson (NYSE:JNJ) today after a Missouri jury ordered the company to pay $72 million in damages to the family of a woman who said her death from cancer was linked to use of the product.

“Johnson & Johnson” was a trending term on Twitter this morning. Social sentiment regarding the company declined today to its lowest levels in the past year, according to a Thomson Reuters social media sentiment analysis index. On other related advertisement about social media, checkout this youtube video marketing company that has high reputation on increasing hits on youtube.

J&J shares were down -37¢ to $103.71 in early afternoon trading today.

In a verdict announced late Feb. 22, jurors in the circuit court of St. Louis awarded the family of Jacqueline Fox $10 million of actual damages and $62 million of punitive damages, according to the family’s lawyers and court records.

On Twitter, several users interpreted the verdict to mean there was a causal link between the talc used in J&J’s products and ovarian cancer, an argument made during the trial by the family’s lawyers.

Jenn (@JennLA82) tweeted, “So baby powder caused ovarian cancer & now Johnson & Johnson must pay 72 million. Congrats to those tireless lawyers. Also…scary.”

Yesterday, a Johnson & Johnson spokeswoman, Carol Goodrich, said the company believes the safety of cosmetic talc is supported by decades of scientific evidence.

Some Twitter users said they would stop using the product.

DayZ (@D_Acevedo213) tweeted: “If talc is dangerous why is it one of your main ingredients?! @JNJNews I’m not using your baby powder in my son anymore.”

Not all were alarmed. Shivam M (@Observer68), tweeted: “After Johnson and Johnson’s, I’m waiting for all the women who eat pounds of lipsticks every year, to sue the respective cosmetics brands.”

Fox, who lived in Birmingham, Ala., claimed she used the company’s Baby Powder and Shower to Shower for feminine hygiene for more than 35 years before being diagnosed 3 years ago with ovarian cancer. She died in October 2015 at age 62.

A J&J spokesman did not respond immediately to a request for comment today.

Filed Under: Legal News, Product Liability Tagged With: Johnson and Johnson

More recent news

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy